1. Funding orphan medicinal products beyond price: sustaining an ecosystem

   • Oriol de Sola-Morales

   Editorial 27 March 2019 Pages: 1283 - 1286

2. The impact of tobacco control policies on smoking initiation in eleven European countries

   • Ali Palali
   • Jan C. van Ours

   Original Paper Open access 09 August 2019 Pages: 1287 - 1301

   

3. Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review

   • Neeru Gupta
   • Holly M. Ayles

   Original Paper 10 August 2019 Pages: 1303 - 1315

   

4. Ex-post moral hazard in the health insurance market: empirical evidence from German data

   • Stefanie Thönnes

   Original Paper 12 August 2019 Pages: 1317 - 1333

   

5. Health state utility values (QALY weights) for Huntington’s disease: an analysis of data from the European Huntington’s Disease Network (EHDN)

   • Annie Hawton
   • Colin Green
   • Timothy Harrower

   Original Paper Open access 13 August 2019 Pages: 1335 - 1347

   

6. The effect of economic growth on obesity for the most obese countries: new evidence from the obesity Kuznets curve

   • Mucahit Aydin

   Original Paper 20 August 2019 Pages: 1349 - 1358

   

7. Modest risk-sharing significantly reduces health plans’ incentives for service distortion

   • Shuli Brammli-Greenberg
   • Jacob Glazer
   • Ruth Waitzberg

   Original Paper 22 August 2019 Pages: 1359 - 1374

   

8. Variations in external reference pricing implementation: does it matter for public policy?

   • Jennifer Gill
   • Anna-Maria Fontrier
   • Panos Kanavos

   Original Paper 23 August 2019 Pages: 1375 - 1397

   

9. Variation in the methodological approach to productivity cost valuation: the case of prostate cancer

   • Paul Hanly
   • Rebecca Maguire
   • Linda Sharp

   Original Paper 23 August 2019 Pages: 1399 - 1408

10. Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review

    • Donghoon Lee
    • Ye-Rin Lee
    • In-Hwan Oh

    Original Paper 26 August 2019 Pages: 1409 - 1424

    

11. Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?

    • Huajie Jin
    • Paul McCrone
    • James H. MacCabe

    Original Paper Open access 28 August 2019 Pages: 1425 - 1435

    

12. Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study

    • Valentina Lorenzoni
    • Stefania Bellelli
    • For the EVINCI Investigators

    Original Paper Open access 13 August 2019 Pages: 1437 - 1449

    

13. Correction to: Cost‑effectiveness analysis of stand‑alone or combined non‑invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study

    • Valentina Lorenzoni
    • Stefania Bellelli
    • For the EVINCI Investigators

    Correction 25 October 2019 Pages: 1451 - 1451